Department of Dermatology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
Dermatological Surgery and Laser Unit, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Clin Exp Dermatol. 2020 Jun;45(4):445-449. doi: 10.1111/ced.14115. Epub 2019 Oct 30.
Tranexamic acid (TA) is an antifibrinolytic agent, increasingly recognized as being of utility for a wide variety of skin diseases. We review the evidence supporting the use of TA for a range of dermatological indications, including (among others) melasma, postinflammatory hyperpigmentation, urticaria, angio-oedema and haemostasis, in addition to practical considerations of its use by dermatologists.
氨甲环酸（TA）是一种抗纤维蛋白溶解剂，越来越多的人认识到它在多种皮肤病中的应用价值。我们回顾了支持 TA 用于一系列皮肤科适应证的证据，包括（除其他外）黄褐斑、炎症后色素沉着过度、荨麻疹、血管性水肿和止血，以及皮肤科医生实际使用时的一些注意事项。
